These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2632760)

  • 1. Evaluation of sodium hyaluronate as viscous vehicle for eye drops.
    Ludwig A; Van Ooteghem M
    J Pharm Belg; 1989; 44(6):391-7. PubMed ID: 2632760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium hyaluronate eyedrops enhance tear film stability.
    Hamano T; Horimoto K; Lee M; Komemushi S
    Jpn J Ophthalmol; 1996; 40(1):62-5. PubMed ID: 8739501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of tear substitutes and their immediate effect on the precorneal tear film.
    Avisar R; Creter D; Levinsky H; Savir H
    Isr J Med Sci; 1997 Mar; 33(3):194-7. PubMed ID: 9313790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous serum eye drops diluted with sodium hyaluronate: clinical and experimental comparative study.
    López-García JS; García-Lozano I; Rivas L; Ramírez N; Raposo R; Méndez MT
    Acta Ophthalmol; 2014 Feb; 92(1):e22-9. PubMed ID: 23890196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic interaction between TS-polysaccharide and hyaluronic acid: implications in the formulation of eye drops.
    Uccello-Barretta G; Nazzi S; Zambito Y; Di Colo G; Balzano F; Sansò M
    Int J Pharm; 2010 Aug; 395(1-2):122-31. PubMed ID: 20580791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative studies of various hyaluronic acids produced by microbial fermentation for potential topical ophthalmic applications.
    Guillaumie F; Furrer P; Felt-Baeyens O; Fuhlendorff BL; Nymand S; Westh P; Gurny R; Schwach-Abdellaoui K
    J Biomed Mater Res A; 2010 Mar; 92(4):1421-30. PubMed ID: 19358259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The instilled fluid dynamics and surface chemistry of polymers in the preocular tear film.
    Benedetto DA; Shah DO; Kaufman HE
    Invest Ophthalmol; 1975 Dec; 14(12):887-902. PubMed ID: 1104516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of the effect of the sodium hyaluronate ophthalmic solution on tear film stability--non-contact specular microscopic evaluation].
    Hamano T; Horimoto K; Lee M; Komemushi S
    Nippon Ganka Gakkai Zasshi; 1993 Aug; 97(8):928-32. PubMed ID: 8368180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium hyaluronate eye drops prevent late-onset bleb leakage after trabeculectomy with mitomycin C.
    Sagara H; Iida T; Suzuki K; Fujiwara T; Koizumi H; Yago K
    Eye (Lond); 2008 Apr; 22(4):507-14. PubMed ID: 17173009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precorneal residence times of sodium hyaluronate solutions studied by quantitative gamma scintigraphy.
    Snibson GR; Greaves JL; Soper ND; Prydal JI; Wilson CG; Bron AJ
    Eye (Lond); 1990; 4 ( Pt 4)():594-602. PubMed ID: 2226990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between precorneal retention of viscous eye drops and tear fluid composition.
    Ludwig A; van Haeringen NJ; Bodelier VM; Van Ooteghem M
    Int Ophthalmol; 1992 Jan; 16(1):23-6. PubMed ID: 1537645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation and in vitro evaluation of cysteamine hydrochloride viscous solutions for the treatment of corneal cystinosis.
    Bozdağ S; Gümüş K; Gümüş O; Unlü N
    Eur J Pharm Biopharm; 2008 Sep; 70(1):260-9. PubMed ID: 18590953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viscous corneal protection by sodium hyaluronate, chondroitin sulfate, and methylcellulose.
    Hammer ME; Burch TG
    Invest Ophthalmol Vis Sci; 1984 Nov; 25(11):1329-32. PubMed ID: 6436190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of hypotonic 0.4% hyaluronic acid drops in dry eye patients: a cross-over study.
    Troiano P; Monaco G
    Cornea; 2008 Dec; 27(10):1126-30. PubMed ID: 19034126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rheology of sodium hyaluronate saline solutions for ophthalmic use.
    Calciu-Rusu D; Rothfuss E; Eckelt J; Haase T; Dick HB; Wolf BA
    Biomacromolecules; 2007 Apr; 8(4):1287-92. PubMed ID: 17355119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of the surface tension of eye drops on the retention of a tracer in the precorneal area of human eyes.
    Ludwig A; Van Ooteghem M
    J Pharm Belg; 1988; 43(3):157-62. PubMed ID: 3171869
    [No Abstract]   [Full Text] [Related]  

  • 17. Corneal calcification following intensified treatment with sodium hyaluronate artificial tears.
    Bernauer W; Thiel MA; Kurrer M; Heiligenhaus A; Rentsch KM; Schmitt A; Heinz C; Yanar A
    Br J Ophthalmol; 2006 Mar; 90(3):285-8. PubMed ID: 16488945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on hyaluronic acid as dendifier in Shuanghuanglian eye-drops].
    Ma ML; Liu L; Sun SY
    Zhongguo Zhong Yao Za Zhi; 2005 Aug; 30(16):1246-8. PubMed ID: 16245899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorophotometric measurement of the precorneal residence time of topically applied hyaluronic acid.
    Mochizuki H; Yamada M; Hato S; Nishida T
    Br J Ophthalmol; 2008 Jan; 92(1):108-11. PubMed ID: 18156377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Low-molecular weight sodium hyaluronate in the treatment of tear film changes and of dry eye].
    Bohm E; Rama P; Tallandini L; Leardini G; de Carli MA
    Ophtalmologie; 1988 Oct; 2(4):353-4. PubMed ID: 3247207
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.